» Articles » PMID: 36084049

Transcriptome Analysis of Homo Sapiens and Mus Musculus Reveals Mechanisms of CD8+ T Cell Exhaustion Caused by Different Factors

Overview
Journal PLoS One
Date 2022 Sep 9
PMID 36084049
Authors
Affiliations
Soon will be listed here.
Abstract

T cell exhaustion is a state of T cell dysfunction during chronic infection and cancer. Antibody-targeting immune checkpoint inhibitors to reverse T cell exhaustion is a promising approach for cancer immunotherapy. However, molecular mechanisms of T cell exhaustion remain incompletely understood. Here, we performed a transcriptome analysis by integrating seven exhaustion datasets caused by multiple diseases in both humans and mice. In this study, an overlap of 21 upregulated and 37 downregulated genes was identified in human and mouse exhausted CD8+ T cells. These genes were significantly enriched in exhaustion response-related pathways, such as signal transduction, immune system processes, and regulation of cytokine production. Gene expression network analysis revealed that the well-documented exhaustion genes were defined as hub genes in upregulated genes. In addition, a weighted gene co-expression analysis identified 175 overlapping genes that were significantly correlated with the exhaustion trait in both humans and mice. This study found that overlapping six genes were significantly upregulated and highly related to T cell exhaustion. Finally, we revealed that CD200R1 and ADGRG1, less described previously in exhaustion, contributed to T cell exhaustion. Overall, our findings reveal the mechanisms of T cell exhaustion and provide an important reference to the immunology community.

Citing Articles

The role of CD8 T-cells in colorectal cancer immunotherapy.

He T, Hu C, Li S, Fan Y, Xie F, Sun X Heliyon. 2024; 10(12):e33144.

PMID: 39005910 PMC: 11239598. DOI: 10.1016/j.heliyon.2024.e33144.


PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma.

Birnbaum D, Picard M, Da Costa Q, Delayre T, Finetti P, Cabaud O Cancers (Basel). 2023; 15(2).

PMID: 36672396 PMC: 9856571. DOI: 10.3390/cancers15020447.

References
1.
Vanneman M, Dranoff G . Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. 2012; 12(4):237-51. PMC: 3967236. DOI: 10.1038/nrc3237. View

2.
Chen J, Dando P, Stevens R, Fortunato M, Barrett A . Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem J. 1998; 335 ( Pt 1):111-7. PMC: 1219758. DOI: 10.1042/bj3350111. View

3.
Kim K, Park S, Park S, Kim G, Park S, Cho J . Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer. Genome Med. 2020; 12(1):22. PMC: 7048139. DOI: 10.1186/s13073-020-00722-9. View

4.
Schurich A, Pallett L, Jajbhay D, Wijngaarden J, Otano I, Gill U . Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host. Cell Rep. 2016; 16(5):1243-1252. PMC: 4977274. DOI: 10.1016/j.celrep.2016.06.078. View

5.
Manoury B, Hewitt E, Morrice N, Dando P, Barrett A, Watts C . An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature. 1999; 396(6712):695-9. DOI: 10.1038/25379. View